1. Home
  2. PODD vs LDOS Comparison

PODD vs LDOS Comparison

Compare PODD & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • LDOS
  • Stock Information
  • Founded
  • PODD 2000
  • LDOS 1969
  • Country
  • PODD United States
  • LDOS United States
  • Employees
  • PODD N/A
  • LDOS N/A
  • Industry
  • PODD Medical/Dental Instruments
  • LDOS EDP Services
  • Sector
  • PODD Health Care
  • LDOS Technology
  • Exchange
  • PODD Nasdaq
  • LDOS Nasdaq
  • Market Cap
  • PODD 21.5B
  • LDOS 21.0B
  • IPO Year
  • PODD 2007
  • LDOS 2006
  • Fundamental
  • Price
  • PODD $331.83
  • LDOS $182.36
  • Analyst Decision
  • PODD Strong Buy
  • LDOS
  • Analyst Count
  • PODD 18
  • LDOS 0
  • Target Price
  • PODD $332.22
  • LDOS N/A
  • AVG Volume (30 Days)
  • PODD 697.4K
  • LDOS 882.8K
  • Earning Date
  • PODD 08-07-2025
  • LDOS 08-05-2025
  • Dividend Yield
  • PODD N/A
  • LDOS N/A
  • EPS Growth
  • PODD N/A
  • LDOS 233.94
  • EPS
  • PODD 3.32
  • LDOS 10.58
  • Revenue
  • PODD $2,359,500,000.00
  • LDOS $17,053,000,000.00
  • Revenue This Year
  • PODD $24.54
  • LDOS N/A
  • Revenue Next Year
  • PODD $17.48
  • LDOS N/A
  • P/E Ratio
  • PODD $99.86
  • LDOS $17.23
  • Revenue Growth
  • PODD 26.00
  • LDOS 6.53
  • 52 Week Low
  • PODD $180.31
  • LDOS $123.62
  • 52 Week High
  • PODD $334.18
  • LDOS $202.90
  • Technical
  • Relative Strength Index (RSI)
  • PODD 68.39
  • LDOS 74.30
  • Support Level
  • PODD $327.17
  • LDOS $176.50
  • Resistance Level
  • PODD $334.18
  • LDOS $183.59
  • Average True Range (ATR)
  • PODD 8.48
  • LDOS 2.93
  • MACD
  • PODD 2.55
  • LDOS 0.11
  • Stochastic Oscillator
  • PODD 95.05
  • LDOS 87.24

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Share on Social Networks: